Zhejiang Huahai Pharmaceutical(600521) Key Financial Indicators

Quotes

Detailed Quotes

Company Overview

Company Profile Company Executives

Financial Analysis

Main Composition Key Indicators Financial Statement

Multi-dimentional Analyses

Company Valuation Capital Tracking Short Selling Data

YOY

Do not show

Hide blank lines

(Q3)2023/03/31(FY)2022/12/31(Q9)2022/09/30(Q6)2022/06/30

Per Share Indicator

Net Asset Per Share

16.71% 5.0521 16.28% 4.9252 5.23% 4.6259 5.98% 4.6271

Basic Earning Per Share

20.00% 0.12 138.24% 0.81 34.15% 0.55 11.43% 0.39

Diluted Earning Per Share

20.00% 0.12 135.29% 0.8 30.95% 0.55 8.33% 0.39

Earning Per Share

26.33% 0.1166 140.88% 0.7872 35.49% 0.5356 10.76% 0.3829

Diluted Earning Per Share（TTM）

226.84% 0.8109 140.88% 0.7872 2.57% 0.4668 -37.40% 0.3639

Capital Surplus Funds Per Share

-3.72% 0.9023 -3.78% 0.891 -10.40% 0.8508 -3.67% 0.9007

Undivided Profit Per Share

30.70% 2.9786 30.89% 2.862 13.13% 2.635 13.25% 2.5816

Operating Cash Flow Per Share

271.83% 0.2521 33.16% 0.8377 -11.53% 0.4037 19.08% 0.3308

Enterprise FCF Per Share

22.78% -0.3387 4.33% -0.9912 -48.78% -1.1999 -176.98% -0.426

Shareholder FCF Per Share

137.62% 0.0673 -62.37% -0.2421 -542.92% -0.758 -178.43% -0.3407

EBIT Per Share

30.58% 0.2216 86.18% 1.148 0.27% 0.6049 12.02% 0.5323

Profitability

ROE Weighted

8.65% 2.260% 122.75% 16.550% 30.30% 11.440% 9.07% 8.300%

ROE

8.75% 2.236% 108.18% 15.474% 28.97% 11.186% 4.71% 7.995%

ROA

2.62% 0.915% 107.11% 6.996% 16.15% 4.972% -3.81% 3.643%

ROIC

8.41% 1.538% 103.15% 9.870% -10.69% 5.394% 2.91% 5.149%

Net Profit Ratio

3.71% 8.184% 96.66% 14.228% 6.64% 13.779% -12.18% 15.073%

Gross Income Ratio

-4.49% 58.875% 3.93% 62.364% 0.19% 61.388% 1.39% 61.991%

EBIT To Total Operating Revenue

11.80% 15.967% 48.82% 20.604% -21.48% 15.372% -11.57% 20.654%

Period Costs Rate

-10.07% 44.649% -22.54% 41.720% -22.47% 41.020% -18.92% 41.529%

Operating Expense Rate

-16.92% 16.746% -15.19% 15.053% -8.78% 17.442% -7.86% 16.958%

Admini Expense Rate

-2.11% 13.816% -18.31% 15.601% -23.12% 14.255% -22.84% 13.902%

Financial Expense Rate

36.96% 4.267% -104.63% -0.131% -175.97% -2.162% -128.05% -0.834%

Recurrent Net Profit

44.34% 188.55M 1,839.98% 1.15B 298.18% 838.34M 223.83% 583.46M

Operating Profit Ratio

4.46% 11.831% 43.20% 18.718% 3.69% 17.649% -14.96% 18.326%

EBIT

29.86% 328.74M 85.16% 1.7B -0.30% 897.39M 11.39% 789.69M

Solvency

Current Ratio

-8.85% 1.6499 2.45% 1.6478 -12.12% 1.673 0.01% 1.8749

Quick Ratio

-6.58% 0.9744 -1.80% 0.9446 -20.80% 0.9091 -14.94% 1.0116

Debt Equity Ratio

4.31% 135.747% 4.74% 134.348% 16.18% 129.975% 11.34% 120.583%

Interest Cover（T）

-18.37% 3.7419 26.70% 8.7703 -- -- -26.39% 8.3414

Shareholders Equity Without Minority Interests To Total Liabilities

-3.42% 71.854% -3.90% 72.520% -14.66% 74.400% -10.17% 80.362%

Shareholders Equity Without Minority Interests To Interest Bear Debt

-7.27% 104.2061% -5.89% 110.8579% -14.80% 109.9867% -7.09% 123.3205%

Long Debt To Working Capital

6.84% 1.8019 4.32% 1.8039 38.50% 1.8117 48.09% 1.6252

Growth Ability

Average Net Profit YOY Past Five Year

-65.85% 6.330% -13.48% 77.983% -28.29% 22.671% -17.31% 19.928%

Sustainable Grow Rate

4.70% 2.233% 248.13% 17.930% 34.45% 12.264% 9.86% 8.787%

Operating Capacity

Operating Cycle（D/T）

1.29% 473.0514 2.43% 452.0368 -3.78% 457.1633 -4.09% 457.8467

Inventory Turnover Days（D/T）

-4.56% 357.3447 2.24% 353.7137 -6.12% 360.7999 -4.56% 364.7519

Accounts Receivable Turnover Days（D/T）

24.91% 115.7067 3.11% 98.3232 6.13% 96.3634 -2.21% 93.0948

Inventory turnover Rate（T）

4.78% 0.2519 -2.19% 1.0178 6.52% 0.7483 4.78% 0.4935

Accounts Receivable Turnover Rate（T）

-19.95% 0.7778 -3.02% 3.6614 -5.78% 2.8019 2.26% 1.9335

Current Assets Turnover Rate（T）

-1.08% 0.256 12.70% 1.1231 20.77% 0.8334 26.75% 0.56

Total Assets Turnover Rate（T）

-0.97% 0.1118 5.49% 0.4917 9.10% 0.3608 9.71% 0.2417

Fixed Assets Turnover Rate（T）

-- -- 4.92% 2.1164 -- -- 8.88% 1.0298

Equity Turnover Rate（T）

0.79% 0.2695 15.30% 1.172 23.73% 0.8547 22.31% 0.5597

Cash Position

Free Cash Flow

23.20% -502.51M 4.87% -1.47B -47.94% -1.78B -175.36% -631.89M

Net Profit Cash Cover

206.92% 221.912% -45.88% 105.670% -35.03% 74.446% 7.03% 85.154%

Operating Revenue Cash Cover

-0.05% 105.049% -6.35% 88.316% -14.62% 91.099% -15.11% 92.058%

Operating Cash In To Assets

214.97% 2.030% 12.29% 7.393% -24.40% 3.701% 3.14% 3.102%

Dividend Ability

Retained Earning Ratio

0.00% 100.000% 43.29% 100.000% 0.00% 100.000% 0.00% 100.000%

Capital Structure

Debt Assets Ratio

1.83% 57.582% 2.02% 57.328% 7.04% 56.517% 5.14% 54.665%

Current Assets To Total Assets

1.16% 43.759% -1.09% 43.562% -7.51% 42.605% -14.90% 42.320%

Non Current Assets To Total Assets

-0.88% 56.241% 0.86% 56.439% 6.42% 57.395% 14.74% 57.681%

Fix Assets Ratio

-- -- 11.76% 24.416% -- -- 13.16% 25.021%

Interest Bearing Debt To Total Capital

4.46% 48.348% 3.70% 46.777% 8.71% 46.786% 4.28% 44.002%

Yield Quality

Invest Revenue From Associates To Total Profit

13.00% -4.625% 47.33% -2.796% 8.32% -3.571% 17.43% -3.346%

Net Income From Value Changes To Total Profit

-111.95% -16.361% -108.17% -4.639% -127.44% -13.656% -118.59% -10.080%

Recurrent Net Profit To Net Profit

19.82% 111.897% 692.89% 98.049% 194.07% 104.221% 192.72% 101.242%

Dupont Analysis

Equity Multipler_DuPont

1.83% 2.411% 9.28% 2.384% 13.38% 2.369% 11.47% 2.316%

Net Profit of Parent Company OwnersTo Net Profit_DuPont

4.25% 102.629% -2.11% 99.298% -0.48% 98.773% -0.43% 98.559%

Net Profit To Total Operating Revenue_DuPont

3.71% 8.184% 96.66% 14.228% 6.64% 13.779% -12.18% 15.073%

Net Profit To Total Profit_DuPont

-1.02% 69.953% 27.60% 77.938% 1.75% 78.583% 2.88% 82.919%

Total Profit To EBIT_DuPont

-6.28% 73.275% 3.56% 88.598% 33.47% 114.066% -3.47% 88.012%

EBIT To Total Operating Revenue_DuPont

11.80% 15.967% 48.82% 20.604% -21.48% 15.372% -11.57% 20.654%

Currency Unit

CNYCNYCNYCNY

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report，MOM=(current period - last period)/last period *100%

Company Overview More

Licensed items: pharmaceutical production; import and export of pharmaceuticals; wholesale of pharmaceuticals; health food sales (for items subject to approval according to law, business activities can only be carried out after approval by relevant departments; specific business projects are subject to the approval results). General projects: technical services, technology development, technical consultation, technology exchange, technology transfer, technology promotion (except for projects subject to approval according to law, independent business activities are carried out on the basis of a business license in accordance with law).

CEO： --

Market： --

Listing Date： 03/04/2003

Futu Hot List

CNHKUS

SearchNews

SymbolLatest price%Chg

Watchlist